BI
PTGX icon

BVF Inc’s Protagonist Therapeutics PTGX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$177M Buy
3,211,041
+636,026
+25% +$35.2M 6.34% 4
2025
Q1
$125M Buy
2,575,015
+675,000
+36% +$32.6M 5.08% 6
2024
Q4
$73.3M Buy
1,900,015
+49,848
+3% +$1.92M 2.49% 7
2024
Q3
$83.3M Sell
1,850,167
-1,469,123
-44% -$66.1M 2.44% 11
2024
Q2
$115M Sell
3,319,290
-436,700
-12% -$15.1M 3.22% 7
2024
Q1
$109M Sell
3,755,990
-1,988,858
-35% -$57.5M 2.99% 8
2023
Q4
$132M Hold
5,744,848
3.3% 4
2023
Q3
$95.8M Buy
5,744,848
+1,968,948
+52% +$32.8M 2.58% 9
2023
Q2
$104M Hold
3,775,900
2.91% 8
2023
Q1
$86.8M Buy
+3,775,900
New +$86.8M 3.17% 6
2022
Q3
Sell
-1,106,838
Closed -$8.76M 82
2022
Q2
$8.76M Sell
1,106,838
-3,076,381
-74% -$24.3M 0.42% 53
2022
Q1
$99.1M Buy
4,183,219
+531,460
+15% +$12.6M 3.96% 7
2021
Q4
$125M Sell
3,651,759
-250,000
-6% -$8.55M 4.53% 5
2021
Q3
$69.1M Buy
3,901,759
+147,664
+4% +$2.62M 2.7% 8
2021
Q2
$168M Sell
3,754,095
-205,356
-5% -$9.22M 6.31% 4
2021
Q1
$103M Sell
3,959,451
-314,137
-7% -$8.14M 3.84% 7
2020
Q4
$86.2M Buy
4,273,588
+1,901,300
+80% +$38.3M 3.39% 9
2020
Q3
$46.4M Buy
2,372,288
+5,000
+0.2% +$97.8K 2.53% 11
2020
Q2
$41.8M Buy
2,367,288
+1,674,858
+242% +$29.6M 2.58% 16
2020
Q1
$4.89M Buy
692,430
+9,800
+1% +$69.2K 0.46% 39
2019
Q4
$4.81M Hold
682,630
0.36% 40
2019
Q3
$8.2M Sell
682,630
-381,172
-36% -$4.58M 0.86% 33
2019
Q2
$12.9M Sell
1,063,802
-59,453
-5% -$720K 1.41% 24
2019
Q1
$14.1M Sell
1,123,255
-516,203
-31% -$6.49M 1.58% 22
2018
Q4
$11M Sell
1,639,458
-978,509
-37% -$6.59M 1.44% 25
2018
Q3
$26.9M Buy
2,617,967
+1,200,000
+85% +$12.3M 2.37% 14
2018
Q2
$9.53M Buy
1,417,967
+1,012,367
+250% +$6.8M 0.93% 29
2018
Q1
$3.48M Buy
405,600
+111,483
+38% +$958K 0.35% 39
2017
Q4
$6.12M Buy
+294,117
New +$6.12M 0.74% 31
2016
Q4
Sell
-375,000
Closed -$7.92M 31
2016
Q3
$7.92M Buy
+375,000
New +$7.92M 1.49% 20